The use of ProstaDoz in patients with chronic prostatitis. results of a multicenter nonrandomized clinical study


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The main purpose of the study was to determine the effectiveness of a multicomponent dietary supplement ProstaDoz in patients with chronic prostatitis. The study included 50 men with clinical symptoms of a chronic prostatitis, which were observed in 9 clinical centers in different regions of Russia. All patients have received 2 capsules of ProstaDoz twice a day for 1 month, followed by dynamic observation for 4 weeks. Symptomatic improvement was achieved in 46 (92%) patients. Evaluation of effects of ProstaDoz on various groups of symptoms has revealed that it reduces pain, promotes urination normalization and improvement of quality of life. These effects were maintained during all follow-up period.

Full Text

Restricted Access

References

  1. Мазо Е.Б., Попов С.В. Хронический бактериальный простатит. Врачебное сословие. 2004; 2: 19-22.
  2. Ефремов Е.А., Дорофеев С.Д., Панюшкин С.М. и др. Сексуальные нарушения при хроническом простатите. Лечащий врач. 2005; 127: 33-36.
  3. Руководство по урологии / Под ред. Н.А. Лопаткина. М., 1998. Т. 2. С. 393-440.
  4. Nickel J.C. Treatment of chronic prostatitis/chronic pelvic pain syndrome. Int. J Antimicrob. Agents. 2008; 31(Suppl. 1): S112-S116.
  5. Тер-Аванесов Г.В. Эффективность препарата Простадоз у мужчин с хроническим простатитом. Клиническое пособие для врачей. Пенткрофт фарма, 2012. С. 2-11.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies